The ZAS Onco Team commenced 2025 on a high note with their annual strategic and planning meeting titled “Leap Into 2025 – Aligning to be Ahead of the Curve.” The event, designed to inspire collaboration and focus, brought team members together to align their vision, set ambitious goals, and lay a robust foundation for the […]
ZAS Onco Team Charts the Course with “Leap Into 2025” Read More »
The ZAS Critical Care Team commenced 2025 on a high note with their annual strategic and planning meeting titled “Leap Into 2025 – Aligning to be Ahead of the Curve.” The event, designed to inspire collaboration and focus, brought team members together to align their vision, set ambitious goals, and lay a robust foundation for
ZAS Critical Care Team Charts the Course with “Leap Into 2025” Read More »
Our Baby Care team recently hosted an engaging and insightful Round Table discussion with leading pediatricians, focusing on the prevention of recurrent respiratory tract infections (RTIs) in children. The session highlighted the role of Lyophilized Bacterial Lysates as a promising solution for boosting immunity and reducing the frequency of RTIs in young patients. The event
Round Table Discussion on Preventing Recurrent RTIs in Children Read More »
As we enter 2025, we are filled with renewed energy and a shared vision for a brighter future. At ZAS, we believe in celebrating the people who drive our success—our champions. This New Year, we’ve captured the aspirations and goals of our dedicated team leaders through heartfelt video messages. ZAS Baby Care Team shares their
ZAS Group celebrates the New Year 2025 with its Champions. Read More »
ZAS Corporation Ltd. is proud to announce the signing of a Memorandum of Understanding (MOU) with The Ibn Sina Trust, marking the beginning of a strategic corporate partnership. This collaboration aims to prioritize the well-being of ZAS employees by providing access to comprehensive health check-ups and premium medical facilities. The agreement underscores ZAS Corporation’s unwavering
ZAS Corporation Headquarters team wrapped up 2024 with an unforgettable recreation tour to the picturesque beaches of Kuakata. Surrounded by serene sea views, the team embraced moments of relaxation, rejuvenation, and connection. The retreat was packed with exciting activities, including games, strategic discussions, and team-building exercises, fostering collaboration and unity. This year-end getaway not only
Rise & Refresh: ZAS Corporation’s Inspiring Year-End Retreat to Kuakata Read More »
ZAS Corporation Ltd. is delighted to announce the signing of a Memorandum of Understanding (MOU) with LABAID Diagnostics and LABAID Cancer Hospital & Super Speciality Centre. This strategic partnership aims to provide employees with access to comprehensive health check-ups and state-of-the-art medical facilities. By joining forces with LABAID, ZAS Corporation reinforces its dedication to fostering
ZAS Corporation proudly launched Uro-Vaxom, an advanced immunotherapeutic solution by OM Pharma, Switzerland, for preventing recurrent urinary tract infections (UTIs). The launch event brought together leading healthcare professionals to discuss Uro-Vaxom’s role in boosting immune defense and reducing UTI recurrence, marking a significant milestone in UTI care. This innovative product reflects ZAS Corporation’s commitment to
ZAS Corporation Introduces Uro-Vaxom to Bangladesh: A Milestone in UTI Prevention Read More »
In collaboration with the Nephrology Department at the National Institute of Kidney Diseases & Urology (NIKDU), ZAS Corporation Ltd. hosted a Virtual CME on “Induction Therapy in Immunologically High-risk vs Low-risk Kidney Transplant Recipients.” Prof. Hüseyin Koçak from Akdeniz University Hospital, Antalya, Türkiye, joined virtually, providing valuable insights into personalized approaches in kidney transplant care.
ZAS Corporation Hosts Virtual CME on Kidney Transplant Induction Therapy Read More »
ZAS Corporation proudly participated in the prestigious MOSB Congress 2024, reaffirming its dedication to advancing oncology care in Bangladesh. The event brought together leading medical professionals, healthcare experts, and pharmaceutical innovators, providing a platform to exchange knowledge and explore the latest breakthroughs in cancer treatment. Our oncology team had the privilege of engaging with esteemed
ZAS Corporation Showcases Commitment to Oncology Care at MOSB Congress 2024 Read More »
